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and Mathias Ried-Larsen1,2
1 Centre of Inflammation and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 2 Centre  
for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 3 Department of 
Endocrinology, Odense University Hospital, Odense, Denmark, 4 OPEN, Odense Patient Data Explorative Network,  
Odense University Hospital, Odense, Denmark
Background and objectives: Ambiguous results have been reported regarding the effects 
of training on resting metabolic rate (RMR), and the importance of training type and intensity 
is unclear. Moreover, studies in subjects with type 2 diabetes (T2D) are sparse. In this study, 
we evaluated the effects of interval and continuous training on RMR in subjects with T2D. 
Furthermore, we explored the determinants for training-induced alterations in RMR.
Methods: Data from two studies, both including T2D subjects, were encompassed in 
this manuscript. Study 1 was a randomized, crossover study where subjects (n = 14) 
completed three, 2-week interventions [control, continuous walking training (CWT), 
interval-walking training (IWT)] separated by washout periods. Training included 10 
supervised treadmill sessions, 60 min/session. CWT was performed at moderate walking 
speed [aiming for 73% of walking peak oxygen uptake (VO2peak)], while IWT was per-
formed as alternating 3-min repetitions at slow (54% VO2peak) and fast (89% VO2peak) 
walking speed. Study 2 was a single-arm training intervention study where subjects 
(n = 23) were prescribed 12 weeks of free-living IWT (at least 3 sessions/week, 30 min/
session). Before and after interventions, RMR, physical fitness, body composition, and 
glycemic control parameters were assessed.
results: No overall intervention-induced changes in RMR were seen across the studies, 
but considerable inter-individual differences in RMR changes were seen in Study 2. At 
baseline, total body mass (TBM), fat-free mass (FFM), and fat mass were all associated with 
RMR. Changes in RMR were associated with changes in TBM and fat mass, and subjects 
who decreased body mass and fat mass also decreased their RMR. No associations were 
seen between changes in physical fitness, glycemic control, or FFM and changes in RMR.
Conclusion: Neither short-term continuous or interval-type training, nor longer term interval 
training affects RMR in subjects with T2D when no overall changes in body composition are 
seen. If training occurs concomitant with a reduction in fat mass, however, RMR is decreased.
Clinical Trials registration (www.ClinicalTrials.gov): NCT02320526 and 
NCT02089477.
Keywords: resting metabolic rate, exercise interventions, exercise training, body composition, physical fitness, 
glycemic control, diabetes type 2
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inTrODUCTiOn
Most subjects with type 2 diabetes (T2D) are overweight or obese, 
and overweight/obesity is considered to be a central component 
of the pathogenesis and pathology of T2D (1, 2). Indeed, weight 
loss is associated with improvements in glycemic control and 
other cardiovascular risk factors, and weight loss is recommended 
for all overweight/obese subjects with T2D (3). Classically spo-
ken, body weight is dependent on the balance between energy 
intake and energy consumption, and a decrease in energy intake 
and/or an increase in energy consumption will lead to a weight 
loss. Energy consumption is dependent on several factors, with 
resting metabolic rate (RMR) being responsible for 60–70% of 
the total energy consumption in subjects who are not very active 
(4). As such, an increase in RMR will increase the likelihood of a 
weight loss, and interventions that may increase RMR would be 
attractive in subjects with T2D.
Exercise increases energy expenditure during and after the 
exercise (5). The increased energy expenditure in the hours 
following an exercise session is known as excess post-exercise 
oxygen consumption (EPOC), and this is dependent on both 
exercise duration and exercise intensity (6). Moreover, training 
interventions may indirectly increase RMR since fat-free mass 
(FFM), which is known to be the predominant determinant of 
RMR (4), is often maintained or increased with training. Since 
subjects with similar FFM may differ substantially in RMR 
(7), FFM is, however, not the only determinant of RMR, and 
although data are conflicting (8), it has been suggested that train-
ing may directly influence RMR. As such, it has been found that 
endurance-trained subjects have higher RMR than sedentary 
matched controls (9–11) and that training interventions may 
increase RMR (10, 12). Conversely, other studies have found 
that training interventions do not affect RMR (13, 14). Whereas 
these discrepancies between studies may be dependent on differ-
ent factors, it has been suggested that VO2max is an important 
determinant for changes in RMR (9, 15), and so the ability of a 
training intervention to increase VO2max may be essential.
Only a few studies examining the effect of training interven-
tions on RMR in diabetic subjects have been performed, and, as 
for healthy subjects, findings are conflicting. Araiza et al. found 
that a training intervention increased RMR (16), whereas Mourier 
et al. and Jennings et al. found no effect of training interventions 
on RMR (17, 18). In subjects with T2D, RMR is typically higher 
compared to matched normal glucose tolerant subjects, some-
thing which is considered to be due to the compromised glycemic 
control (19, 20). Whereas Araiza et al. found no improvements in 
glycemic control with their training intervention, both Mourier 
and Jennings et  al. did see training-induced improvements in 
glycemic control. Thus, it might be speculated whether training-
induced improvements in RMR were blunted or even completely 
offset by the training-induced improvements in glycemic control 
in the two latter studies.
Exercise intensity is an important determinant for training-
induced changes in body composition (21), and we have previously 
found that 17 weeks of interval-walking training (IWT) results in 
a substantial weight loss (on average 4 kg) in opposition to time 
duration and energy-expenditure matched continuous walking 
training (CWT) (22). Whereas part of this differential weight 
loss between CWT and IWT may be explained via differential 
EPOC (23), the main reason for the discrepancy remains unclear. 
There are some indications that training with higher intensity 
may increase RMR more than training with lower intensity, but 
it is unclear if this is due to differential effects on VO2max and 
other potential determinants for RMR, or if there is a direct effect 
of higher training intensity on RMR (24). As such, we aimed 
to examine the direct effects (independent of changes in body 
composition and VO2max) of short-term (2 weeks) IWT/CWT 
and the effects of longer term (12 weeks) IWT on RMR in subjects 
with T2D. Moreover, we aimed to assess the associations between 
potential determinants for RMR (VO2max, body composition, 
glycemic control) and RMR, both at baseline and in relation to 
the changes induced with 12 weeks of IWT.
MaTErialS anD METHODS
This manuscript builds on data from two different studies, both 
including subjects with T2D (25). Exclusion criteria were preg-
nancy, smoking, contraindication to increased levels of physical 
activity (26), insulin dependence, and evidence of thyroid, 
liver, lung, heart, or kidney disease. All subjects underwent a 
screening consisting of a medical interview and examination, 
an oral glucose tolerance test (OGTT), a walking VO2peak test 
with indirect calorimetry (Cosmed K4B2, Rome, Italy) and a 
familiarization VO2max test performed on a treadmill (Katana 
Sport, Lode, Groningen, the Netherlands) with indirect calo-
rimetry (Cosmed Quark, Rome, Italy) as previously described 
(22, 27). Written and informed consent was obtained from all 
research participants before any investigations were performed 
and the studies were approved by the Ethical Committee of the 
Capital Region of Denmark (H-6-2014-043 and H-1-2013-116) 
and registered at www.ClinicalTrials.gov (NCT02320526) and 
(NCT02089477).
Study Designs and interventions
Study 1 was a randomized, crossover trial where subjects were 
included in three different interventions, each lasting 2 weeks. The 
interventions were CWT (ten 60-min walking sessions performed 
with a continuous speed, aiming for oxygen uptake rates at 73% 
of VO2peak); IWT [ten 60-min walking sessions performed with 
cycles of alternating 3-min slow (54% of VO2peak) and 3-min fast 
(89% of VO2peak) walking]; control (CON) (no walking), and 
interventions were performed in randomized order. All walk-
ing sessions were performed at a treadmill (Katana Sport) and 
controlled with indirect calorimetry at the first and sixth session 
(in order to determinate the walking speed that corresponded to 
the correct oxygen uptake rates). Between interventions, washout 
periods (8  weeks after CWT/IWT, 4  weeks after CON), where 
subjects returned to their habitual activity level, were applied to 
ensure that any intervention-induced effects disappeared before 
initiation of the next intervention. Other data from this study 
have previously been published (28).
Study 2 was a single-arm intervention study, where subjects 
were prescribed free-living IWT for 12 weeks. Subjects were told 
TaBlE 1 | Pre- and (for Study 2) post-intervention characteristics.
Study 1 Study 2 pre Study 2 post
n 14 23
Sex (M/F) 11/3 7/16
Age (years) 65.3 ± 1.7 64.8 ± 1.5
Time since diagnosis (years) 8.6 ± 1.3 6.0 ± 0.9
Glucose-lowering medication (n)
Metformin 14 19
Sulfonylureas 3 2
GLP-1 analogs/DPP-4 inhibitors 3 7
SGLT2 inhibitors 0 1
rMr
Absolute (ml O2/min) 1,736 ± 85 1,659 ± 51 1,646 ± 69
Relative to body mass (ml O2/min/kg TBM) 18.1 ± 0.6 21.4 ± 0.8* 21.0 ± 0.7
Relative to FFM (ml O2/min/kg FFM) 28.8 ± 1.1 34.4 ± 0.8* 34.0 ± 1.1
Physical fitness (VO2max)
Absolute (ml O2/min) 2,438 ± 147 1,961 ± 90 2,065 ± 92‡
Relative to body mass (ml O2/min/kg TBM) 25.3 ± 1.1 25.1 ± 1.0 26.3 ± 0.8‡
Relative to FFM (ml O2/min/kg FFM) 41.3 ± 3.7 40.0 ± 1.1 42.1 ± 0.8(‡)
Body composition
BMI (kg/m2) 31.6 ± 1.1 28.8 ± 1.3 28.7 ± 1.2
TBM (kg) 98.3 ± 4.7 79.7 ± 3.5* 79.3 ± 3.4
FFM (kg) 61.5 ± 3.2 48.8 ± 1.8* 48.7 ± 1.8
Fat mass (kg) 36.8 ± 2.1 30.6 ± 2.5 30.2 ± 2.5
Fat percentage (%) 38.0 ± 1.5 38.8 ± 2.0 38.5 ± 2.1
Glycemic control
Fasting glucose (mmol/l) 7.7 ± 0.5 6.9 ± 0.4 7.1 ± 0.4
Fasting insulin (pmol/l) 119 ± 35 72 ± 10 83 ± 10
Two-hour OGTT glucose (mmol/l) 13.1 ± 1.3 14.4 ± 0.7 14.1 ± 0.7
Mean OGTT glucose 13.0 ± 0.7 13.4 ± 0.6 13.2 ± 0.6
HbA1c (mmol/mol) 47.7 ± 2.4 50.1 ± 2.5 50.5 ± 2.3
Thyroid hormones
TSH (×10−3 IU/L) 1.8 ± 0.3 1.6 ± 0.2 1.7 ± 0.2
Triiodothyronine (nmol/l) 1.6 ± 0.1 1.6 ± 0.1 1.6 ± 0.1
Thyroxine (nmol/l) 96.7 ± 6.1 87.3 ± 2.7 89.5 ± 2.9
Data are numbers (n) or mean ± SEM.
GLP-1, glucagon-like peptide-1; DPP-4, dipeptidyl peptidase-4; SGLT2, sodium-glucose cotransporter-2; RMR, resting metabolic rate; VO2max, maximal oxygen consumption rate; 
TBM, total body mass; FFM, fat-free mass; BMI, body mass index; OGTT, oral glucose tolerance test; HbA1c, hemoglobin A1c; TSH, thyroid-stimulating hormone.
Statistical differences are indicated by *(p < 0.05, Study 1 vs. Study 2 pre, Student’s unpaired t-test) and ‡(p < 0.05, Study 2 pre vs. study 2 post, Student’s paired t-test). 
(‡)indicates p < 0.10.
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to complete at least three weekly training sessions, each last-
ing at least 30 min and with repeated cycles of 3-min fast and 
3-min slow walking. Training was controlled by a smartphone 
application (InterWalk®), and data from training sessions were 
uploaded to a central server (29). Other data from this study have 
previously been published (27).
investigations
Before (pre) and after (post) interventions, subjects underwent 
one experimental day (meaning that subjects in Study 1 com-
pleted 6 experimental days in total). Subjects met fasting (~12 h 
for all except water) in the laboratory, by means of passive trans-
port (car, bus, etc.). After confirming that no subjective feeling of 
acute disease and no fever was present, subjects voided. Subjects 
were then weighted, had an antecubital vein catheter inserted, 
and were placed in a bed in a temperature controlled (20°C) and 
calm room. After an acclimatization period of at least 30 min, the 
RMR measurements commenced: a standardized head tilt (15°) 
was applied to the bed and a ventilated hood (Cosmed, rounded 
canopy) was placed over the subject’s head and connected to 
an indirect calorimetric system (Cosmed Quark) via a canopy 
blower (Cosmed). Carbon dioxide concentrations in the system 
were kept below 1% to avoid excess breathing (30). Subjects 
were instructed to breathe normally and not to fall asleep. RMR 
measurements were performed for 20 min.
Following the RMR measurements, fasting blood samples 
(lithium-heparin and EDTA tubes) were obtained and subjects 
included in Study 1 underwent supine resting whereas subjects in 
Study 2 underwent a 2 h standard OGTT (75 g anhydrate glucose 
dissolved in water to a total volume of 300  ml) with bedside 
blood glucose measurements (ABL 8 series, Radiometer, Herlev, 
Denmark) obtained every 30  min. Finally, following resting/
OGTT procedures, all subjects were given a light meal and under-
went a dual-energy X-ray absorptiometry scan (Lunar Prodigy 
Advance; GE Healthcare, Madison, WI, USA) and a VO2max test 
comparable to the one performed at the screening day.
FiGUrE 1 | The effect of training interventions on resting metabolic rate (RMR). Subjects with type 2 diabetes underwent three 2-week interventions (a–C); no 
training [control (CON)], continuous walking training (CWT), interval-walking training [IWT or 12 weeks of IWT training (D–F)]. RMR was measured before and after 
interventions and is reported as total RMR (a,D), RMR relative to total body mass [TBM (B,E)] and RMR relative to fat-free mass [FFM (C,F)]. Data are shown as 
mean ± SEM (a–C) and mean + individual data (D–F). Statistical analyses [two-way repeated-measures ANOVA in Panels (a–C)] and Student’s paired t-test  
(D–F) did not result in any significant changes within interventions (p > 0.05 for all comparisons).
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Post-intervention investigations were in Study 1 initiated 
39–43 h after the last exercise bout (in CWT/IWT interventions), 
and in Study 2 at least 48 h after the last exercise bout.
analyses and Calculations
Fasting blood samples were centrifuged (2,000 g, 15 min, 4°C). 
Lithium-heparin plasma was analyzed for thyroid hormones 
(thyroid-stimulating hormone, triiodothyronine, and thyroxine) 
and insulin via Electrochemiluminescence immunoassay (Cobas 
8000, Roche Diagnostics, IN, USA). EDTA plasma was analyzed 
for HbA1c via absorption photometry (Tosoh G7; Tosoh, San 
Francisco, CA, USA).
Mean oxygen uptake and carbohydrate excretion rates were 
calculated from the indirect calorimetric measurements. RMR 
was calculated according to the equations by Weir (31).
Statistics
First, intervention-induced effects on RMR were compared using 
two-way (time × intervention) repeated-measures (RM) ANOVA 
(Study 1) and Student’s paired t-test (Study 2).
Next, simple linear regression analyses between potential 
determinants of RMR (VO2max, body composition, and gly-
cemic control variables) and RMR were performed on baseline 
data (both studies) and on post–pre intervention (delta) values 
(Study 2). To avoid regression toward the mean, all delta values 
were controlled for baseline values, and this did not change the 
results of the regression analyses.
Finally, due to large between-subject heterogeneity in RMR 
responses in Study 2, subjects were stratified into three groups 
according to the intervention-induced effect on RMR as 
(1) decreased RMR (≥  10% decrease); (2) unchanged RMR; 
(3) increased RMR (≥10% increase). The specific cutoff levels 
were chosen to ensure that subjects categorized in group 1 and 
3 with certainty had intervention-induced alterations in RMR 
and that the differences measured were not just due to impreci-
sion of the measurements or biological day-to-day variation 
(30, 32). Stratified analyses were performed as one-way ANOVA 
of baseline values (to assess baseline differences between strata), 
as one-way RM ANOVA of delta values between strata (to assess 
differential changes in potential determinants of RMR between 
strata), and as two-way (time  ×  stratification) RM ANOVA’s 
(to assess differential changes in potential determinants of RMR 
within each strata).
Data are reported as mean ± SEM or delta values with con-
fidence intervals (CI). All analyses were performed using Prism 
v6.03 (Graphpad Software, CA, USA) and statistical significance 
was accepted when p < 0.05.
rESUlTS
Baseline data are given in Table 1. N = 14 subjects were included 
in Study 1 with all subjects being included in the analyses. 
N = 32 subjects were included in Study 2, but only 23 subjects 
underwent RMR measurements. As such, N = 37 subjects were 
overall included in the current analyses. No subjects changed 
glucose-lowering medication during the study period. In Study 
1, glucose-lowering medication was continued unchanged during 
the entire study, whereas, in Study 2, glucose-lowering medica-
tion was paused from 2 days before each experimental day and 
until the end of the experimental day.
Training Data
In Study 1, training adherence (amount of training performed 
relative to prescribed) was 99% in both CWT and IWT. As previ-
ously published (28), mean oxygen consumption and heart rates 
were comparable between CWT and IWT, whereas fast and slow 
FiGUrE 2 | Baseline associations between resting metabolic rate (RMR) and potential determinants of RMR. Simple regression analyses were performed between 
baseline values of potential determinants of RMR (x-axis) and baseline RMR (y-axis). The potential determinants were VO2max [absolute, relative to total body mass 
(TBM), and relative to fat-free mass (FFM) (a–C)], body composition [body mass, FFM, and fat mass (D–F)] and glycemic control [fasting glucose, mean oral glucose 
tolerance test (OGTT) glucose, and 2 h OGTT glucose (G–i)]. Data from both Study 1 (open circles) and Study 2 (black circles) were included in the regression 
analyses and results (β-coefficients, r2-, and p-values) are given in each panel.
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IWT intervals were performed with higher and lower oxygen 
consumption and heart rates, respectively, compared to CWT.
In Study 2, the mean uploaded IWT time was 68 ± 9 min/week, 
corresponding to 75% of the minimal volumes of prescribed 
training. There were, however, substantial between-subject dif-
ferences in uploaded IWT time, with six individuals uploading 
less than 30% of the minimal volumes of prescribed training. 
If excluding these six, apparently non-adherent, subjects from 
the analyses, mean uploaded IWT time was 85 ± 7 min/week, 
corresponding to 94% of the minimal amounts of prescribed 
training. It was not possible to assess training intensity from the 
uploaded data.
intervention-induced Effects on rMr
In Study 1, no effect of any intervention was found on RMR 
[delta CON  =  −33 (95% CI: −122 to 57)  kcal/24  h, delta 
CWT = −32 (95% CI: −122 to 58) kcal/24 h, delta IWT = 62 
(95% CI: −28 to 152) kcal/24 h, p > 0.05 for all comparisons] 
(Figure 1). Likewise, in Study 2, no overall intervention-induced 
change in RMR was found [delta IWT = −13 (95% CI: −125 
to 98) kcal/24 h, p > 0.05], and exclusion of the subjects who 
were apparently non-adherent to the training (n  =  6), did 
not change this. Moreover, no association was seen between 
uploaded IWT time and changes in RMR (r2 = 0.05, p = 0.34) 
However, intervention-induced changes in RMR varied consid-
erably between subjects (Figures 1D–F). As such, n = 7 subjects 
decreased RMR (≥10%), n = 9 subjects did not change RMR and 
n =  7 subjects increased RMR (≥10%) with the intervention. 
Normalization of RMR to total body mass (TBM) or FFM did 
not alter the above-standing results.
Potential Determinants of rMr
In Study 1, no intervention-induced effects on physical fitness or 
body composition was seen with any of the interventions (p > 0.05 
for all comparisons, data not shown) (Table 1). Conversely, and 
as previously described (28), measures of glycemic control (mean 
FiGUrE 3 | Associations between delta (post minus pre intervention) values of resting metabolic rate (RMR) and delta values of potential determinants of RMR. 
Simple regression analyses were performed between delta values of potential determinants of RMR (x-axis) and delta values of RMR (y-axis). The potential 
determinants were VO2max [absolute, relative to total body mass (TBM) and relative to fat-free mass (FFM) (a–C)], body composition [body mass, FFM and fat mass 
(D–F)] and glycemic control [fasting glucose, mean oral glucose tolerance test (OGTT) glucose, and 2 h OGTT glucose (G–i)]. Data from Study 2 were included in 
the regression analyses and results (β-coefficients, r2-, and p-values) are given in each panel.
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and maximum 24 h glucose levels) were improved with IWT, with 
no effects of CON or CWT.
In Study 2, physical fitness improved with the intervention 
[delta VO2max = 104 (CI: 11–197) ml/min, p < 0.05], whereas nei-
ther body compositional nor glycemic control variables improved 
with the intervention (Table 1, p > 0.05 for all comparisons).
associations between Potential  
rMr-Determinants and rMr
Baseline levels of VO2max were positively correlated with RMR 
(Figures 2 and 3). When normalizing VO2max to body mass or 
FFM, however, the association disappeared. No significant asso-
ciations between delta values in VO2max and RMR were seen.
Body compositional variables (TBM, FFM, and fat mass), 
were all positively correlated with RMR at baseline. When 
analyzing delta values, the associations between TBM/fat mass 
and RMR were maintained, whereas no association between 
FFM and RMR was seen. The association between changes in 
fat mass and RMR was maintained when a sequential correc-
tion for changes in the other potential RMR-determinants was 
performed.
No associations between glycemic control variables (fasting 
glucose, mean OGTT glucose, 2 h OGTT glucose, HbA1c) and 
RMR were seen, neither at baseline nor when analyzing delta 
values.
Changes in Potential rMr-Determinants 
in Stratified analyses
No baseline differences in RMR or any potential determinants 
of RMR (measures of VO2max, body compositional variables, 
TaBlE 2 | Stratified analyses in Study 2.
Decreased rMr Unchanged rMr increased rMr
Pre Post Pre Post Pre Post
rMr
Total (kcal/24 h)†# 1,616 ± 102 1,308 ± 69* 1,751 ± 85 1,735 ± 95 1,586 ± 78 1,871 ± 92*
Relative to body mass (kcal/24 h/kg TBM)# 36.4 ± 0.9 30.0 ± 0.6* 34.9 ± 1.2 34.4 ± 1.7 31.8 ± 1.7 37.6 ± 2.1*
Relative to FFM (kcal/24 h/kg FFM)# 23.7 ± 1.4 19.7 ± 1.2* 21.6 ± 1.0 21.4 ± 1.0 18.7 ± 1.1 21.9 ± 1.4*
Physical fitness (VO2max)
Absolute (ml O2/min)‡ 1,681 ± 88 1,721 ± 154 2,141 ± 135 2,225 ± 151 2,034 ± 190 2,171 ± 146
Relative to body mass (ml O2/min/kg TBM)‡ 24.8 ± 1.6 25.3 ± 1.0 28.2 ± 2.2 29.2 ± 2.3 24.0 ± 2.2 25.2 ± 1.4
Relative to FFM (ml O2/min/kg FFM)(‡) 38.0 ± 1.0 40.5 ± 2.3 43.3 ± 2.2 43.9 ± 2.3 40.4 ± 3.0 43.1 ± 1.2
Body composition
Body mass (kg)# 70.1 ± 7.0 68.4 ± 6.4* 82.0 ± 5.1 81.9 ± 4.8 86.4 ± 5.7 87.0 ± 5.6
FFM (kg) 44.6 ± 3.2 43.9 ± 3.1 50.6 ± 3.0 51.1 ± 3.0 50.6 ± 3.3 50.5 ± 3.1
Fat mass (kg)# 25.4 ± 5.0 24.0 ± 4.6* 30.9 ± 4.2 30.7 ± 4.2 35.2 ± 3.4 35.9 ± 3.4
Fat percentage (%) 36.0 ± 3.9 35.2 ± 4.0 38.2 ± 3.8 37.9 ± 3.9 42.2 ± 2.1 42.7 ± 2.0
Glycemic control
Fasting glucose (mmol/l) 6.2 ± 0.5 6.5 ± 0.6 6.5 ± 0.2 6.7 ± 0.2 8.0 ± 1.2 8.2 ± 1.0
2 h OGTT glucose (mmol/l)(†) 15.5 ± 0.9 14.5 ± 1.4 12.4 ± 1.4 12.6 ± 1.0 15.8 ± 1.2 15.7 ± 1.1
Mean OGTT glucose (mmol/l)(†) 13.8 ± 0.9 13.0 ± 1.3 12.2 ± 0.9 11.9 ± 0.6 14.7 ± 1.1 15.1 ± 0.7
HbA1c (mmol/mol) 49.9 ± 4.6 48.6 ± 3.4 47.1 ± 1.2 48.6 ± 1.6 53.9 ± 6.2 54.7 ± 6.4
Subjects with type 2 diabetes underwent a 12-week interval-walking training intervention, with measurements of resting metabolic rate (RMR), physical fitness, body composition, 
and glycemic control before (Pre) and after (Post) the intervention. Subjects were stratified according to the intervention-induced change in RMR as decreased RMR (≥10%), 
unchanged RMR or increased RMR (≥10%), and the intervention-induced changes in potential determinants of RMR were analyzed using a two-way repeated-measures ANOVA for 
within-strata changes. Data are presented as mean ± SEM.
Statistical differences are indicated by ‡(main effect of time), †(main effect of stratification), #(time × stratification interaction), *(within group, pre vs. post, p < 0.05). Parenthesis 
indicates p < 0.10.
TBM, total body mass; FFM, fat-free mass; OGTT, oral glucose tolerance test; HbA1c, hemoglobin A1c.
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glycemic control variables) were seen between strata (p >  0.05 
for all comparisons) (Table 2; Figure 4).
For measures of VO2max and glycemic control, no 
intervention-induced changes within strata were seen, nor were 
there any intervention-induced differences between strata.
An intervention-induced reduction in body mass was seen in 
subjects who also decreased RMR, and a between-strata differ-
ence in body mass was seen between subjects who decreased and 
subjects who increased RMR (p < 0.05 for both).
Whereas the results for fat mass mirrored those seen for TBM, 
no differences within or between strata was seen for FFM.
Hormone levels
In Study 1, no intervention-induced effects on fasting insulin or 
thyroid hormones were seen with any of the interventions (data 
not shown, p > 0.05 for all comparisons).
In Study 2, fasting insulin and thyroid hormones did not 
change with the intervention, and likewise, no differences were 
seen in the stratified analyses (data not shown, p > 0.05 for all 
comparisons).
DiSCUSSiOn
The most important finding of this study is that neither short-
term continuous or interval-based training nor longer term 
interval-based training altered RMR in subjects with T2D as 
long as the training did not alter body composition. Body com-
position, both FFM and fat mass, were important determinants 
for RMR at baseline, but, interestingly, only training-induced 
changes in fat mass and not in FFM were associated with 
training-induced changes in RMR. This was supported by the 
stratified analyses, were subjects with a training-induced loss of 
fat mass had an accompanying decrease in RMR.
The lack of training-induced changes in RMR is in line with 
most previous studies. Both in healthy subjects (13, 14) and in 
subjects with T2D (17, 18), it is most commonly reported that 
RMR does not change with a training intervention. However, 
some studies have found increased RMR after a training inter-
vention (10, 12, 16). Whereas parts of the explanation for the 
conflicting findings may be due to different training modalities 
(33), and differential changes in body composition, it is also 
possible that the post-intervention RMR measurement has been 
performed too early after the last exercise bout in some studies, 
implying that EPOC has been included in the measurement (6). 
Whereas we did not see any significant changes in RMR in any of 
the two studies in the primary analyses, a paired t-test indicated 
a tendency for increased RMR with IWT in Study 1 (p = 0.06). 
Since EPOC is increased with IWT compared to both CON and 
CWT (23), and since our RMR measurements were performed 
~40 h after the last exercise bout, it is possible that the tendency 
for increased RMR seen with IWT in Study 1 in fact was pro-
longed EPOC (8).
In contrast to previous observations (19, 20), we did not find 
any indication that glycemic control affected RMR. Increased 
RMR has mainly been reported in subjects with dysregulated 
diabetes (5) and the subjects included in our studies had a 
fairly good glycemic control both at baseline and after the 
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interventions; potentially too good to affect RMR. Also, the pre-
viously reported positive correlation between VO2max and RMR 
(9, 15), was not replicated in our data when VO2max relative to 
body weight or FFM was used, neither for baseline values nor 
for intervention-induced changes. Since an association between 
changes in VO2max and glycemic control has previously been 
described in subjects with T2D (34), it would hypothetically 
be possible that subjects who increased VO2max the most also 
improved glycemic control the most, and that the combined and 
opposing effect of these determinants resulted in no changes 
in RMR. However, since no associations were seen between 
changes in VO2max/glycemic control and changes in RMR and 
since no associations were found between changes in VO2max 
and changes in glycemic control (data not shown), we find this 
unlikely.
The strong baseline associations we found between FFM and 
fat mass on one side and RMR on the other side have previously 
been reported (35). Interestingly, when comparing intervention-
induced changes in Study 2, the association between FFM and 
RMR disappeared, whereas the association between fat mass 
and RMR persisted. Moreover, subjects who decreased RMR 
with the training intervention also lost fat mass. Whereas FFM 
is considered to be the primary determinant for RMR and 
training-induced changes in RMR are most often explained by 
changes in FFM (4, 8), it has also been reported that a training-
induced loss of fat mass may “overrule” the effect of an increase in 
FFM on RMR since this combination has been shown to decrease 
RMR (36). The mechanisms underlying these results cannot read-
ily be derived from our data. It is generally believed, however, that 
the body responds to a weight loss with a homeostatic energy 
sparring, which is mainly seen as decreased RMR dependent on 
reductions in hormones like insulin and triiodothyronine (37) 
and reduced activity of the sympathetic nervous system (38). 
This has mainly been shown for a weight loss arising from dietary 
energy restriction (39–41), but may also be seen when at least 
parts of the weight loss is mediated via increased physical activ-
ity (42, 43). Whereas we did not see any changes in insulin or 
thyroid hormones with any of the training interventions, we did 
not measure sympathetic nervous system activity. Since changes 
in sympathetic nervous system activity are closer associated with 
changes in fat mass than with changes in FFM (44), it is plausible 
that the subjects who lost fat mass in Study 2 had a reduction 
in RMR due to a decreased activity of the sympathetic nervous 
system.
While Study 1 was fully supervised efficacy trial with high 
training adherence, Study 2 was a free-living effectiveness trial 
FiGUrE 4 | Stratified analyses of potential determinants for resting metabolic rate (RMR). Subjects included in Study 2 were stratified according to their change in 
RMR as increased RMR (≥10%, n = 7), unchanged RMR (n = 9), or decreased RMR (≥10%, n = 7). Delta (post minus pre intervention) values ± SEM of potential 
determinants for RMR {VO2max [absolute, relative to total body mass (TBM), and relative to fat free mass (FFM); panel (a–C)], body composition [body mass, fat free 
mass, and fat mass; panel (D–F)], and glycemic control [fasting glucose, mean OGTT glucose, and 2 h OGTT glucose; panel (G–i)]} are shown for the different 
strata. Within-strata changes in potential determinants of RMR were analyzed by two-way (strata × time) repeated-measures (RM) ANOVA (significant changes 
indicated by an asterisk above the bar) and between-strata differences were analyzed by one-way RM ANOVA of the delta values (significant changes indicated by a 
connecting line and an asterisk).
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without supervision. Whereas the training adherence in Study 2, 
in terms of volume, was fairly good compared to other free-living 
training studies (45, 46), the training adherence, in terms of 
intensity, was not possible to assess. Since no overall changes in 
glycemic control and body composition were seen in Study 2, 
it must be speculated how good the training adherence was. 
Subjects improved their VO2max, however, indicating that some 
effect of the training was seen. Still, when compared to our 
previous study, where 17 weeks of IWT resulted in considerable 
weight loss and improvements in glycemic control and a much 
greater increase in VO2max (22), it is clear that subjects included 
in the current Study 2 had suboptimal training responses. The 
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Given that the analyses in this paper were secondary to other 
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since a large heterogeneity was seen for changes in RMR. As such, 
despite the overall analyses indicated that RMR was unaffected 
by the training interventions, no final conclusions can be drawn 
from this paper.
In summary, neither short-term continuous or interval-type 
training, nor longer term interval training affects RMR in subjects 
with T2D when no overall changes in body composition are seen. 
Whereas both FFM and fat mass are important determinants of 
RMR at baseline, only training-induced changes in fat mass and 
not in FFM seem to be important for training-induced changes 
in RMR.
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